Daiken Medical Co., Ltd. (TYO:7775)
Japan · Delayed Price · Currency is JPY 416.00
-1.00 (-0.24%)
Jun 23, 2026, 10:51 AM JST
Daiken Medical Revenue
In the fiscal year ending March 31, 2026, Daiken Medical had annual revenue of 10.29B JPY with 3.41% growth. Daiken Medical had revenue of 2.41B in the quarter ending March 31, 2026, with 5.42% growth.
Revenue
10.29B
Revenue Growth
+3.41%
P/S Ratio
1.16
Revenue / Employee
57.17M
Employees
180
Market Cap
11.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 10.29B | 339.00M | 3.41% |
| Mar 31, 2025 | 9.95B | 201.00M | 2.06% |
| Mar 31, 2024 | 9.75B | 613.00M | 6.71% |
| Mar 31, 2023 | 9.14B | 597.00M | 6.99% |
| Mar 31, 2022 | 8.54B | 679.00M | 8.64% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medius Holdings | 296.86B |
| JMS Co.,Ltd. | 65.85B |
| Shofu | 39.99B |
| SEED Co.,Ltd. | 33.94B |
| Medikit | 23.78B |
| Japan Eyewear Holdings | 19.30B |
| Shigematsu Works | 15.59B |
| Kitazato | 10.95B |
Daiken Medical News
- 5 months ago - Elastomeric Infusion Pumps Market worth $1.49 billion by 2030 at 5.3%, says MarketsandMarkets™ - Benzinga
- 7 months ago - Elastomeric Infusion Pumps Market worth $1.49 billion by 2030, at a CAGR of 5.3%, says MarketsandMarkets™ - Benzinga